Giampaolo Greco, PhD
- ASSISTANT PROFESSOR | Population Health Science and Policy
Dr. Greco graduated at the University of Rome and trained in immunological research at the Superior Institute of Health in Italy. As a biomedical researcher, Dr. Greco contributed with numerous and significant publications in the fields of cancer immunotherapy and HIV research. In 2005, Dr Greco joined the International Center for Health Outcomes and Innovation Research (InCHOIR) at Columbia University and in 2007 became assistant clinical professor of Health Policy and management at the Mailman School of Public Health . Dr. Greco joined Mount Sinai in 2008 as an Assistant Professor in the department of Population Health Science & Policy. Dr. Greco's research utilizes methodologies such as cost-effectiveness analysis and large dataset analysis. Using outcome and cost data stored in large insurance databases or the quality and safety data from medical event reporting systems, Dr. Greco has analyzed the effectiveness of different technologies, their diffusion, outcomes, costs and patterns of utilization in different segments of the population, and evaluated the economic impact of medical errors in the hospital.
PhD, University of Rome
MPH, Columbia University
Screening for Vascular Diseases:
Identifying individuals at risk for vascular disease and examine the cost effectiveness criteria that would bring the use of screening for vascular disease into common general practice.
Economic impact of medical errors.
Egorova NN, Gelijns AC, Moskowitz AJ, Emond JC, Krapf R, Lazar EJ, Guillerme S, Kaplan HS, Greco G. Process of Care Events in Transplantation: Effects on the Cost of Hospitalization. . Am J Transplant. 2010; 10: 1-8.
Greco G, Egorova N, Gelijns A, Moskowitz A, Zwolak R, Riles T, Manganaro A, Kent K. Development of a Novel Scoring Tool for the Identification of Large ≥ 5 cm Abdominal Aortic Aneurysms. Annals of Surgery Accepted 2010;.
Kent K, Zwolak R, Egorova N, Riles T, Manganaro A, Moskowitz A, Gelijns A, Greco G. Analysis of Risk Factors for Abdominal Aortic Aneurysm in a Cohort of More Than 3 Million Individuals. J Vasc Surg. Accepted 2010;.
Egorova N, Giacovelli J, Gelijns A, Greco G, Moskowitz A, McKinsey J, Kent K. Defining high-risk patients for endovascular aneurysm repair. J Vasc Surg 2009; 50: 1271-1279.
Egorova N, Giacovelli J, Greco G, Gelijns A, Kent K, McKinsey J. National Outcomes for the Treatment of Ruptured Abdominal Aortic Aneurysm: Comparison of Open Versus Endovascular Repairs. J Vasc Surg 2008; 48: 1092-1100.
Egorova N, Moskowitz A, Gelijns A, Weinberg A, Curty J, Rabin-Fastman B, Kaplan H, Cooper M, Emond J, Greco G. Managing the prevention of retained surgical instruments: what is the value of counting? . Annals of Surgery 2008; 247(13-1).
Morrissey NJ, Giacovelli J, Egorova N, Gelijns A, Moskowitz A, McKinsey J, Kent K, Greco G. Disparities in the Treatment and Outcomes of Vascular Disease in Hispanic Patients. J Vasc Surg 2007; 46: 971-978.
Nowygrod R, Egorova N, Greco G, Anderson P, Gelijns A, Moskowitz A, McKinsey J, Morrissey N, Kent K. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 2006; 43: 205-216.
Greco G, Egorova N, Anderson P, Gelijns A, Moskowitz A, Nowygrod R, Arons R, McKinsey J, Morrissey N, Kent K. Outcomes of endovascular treatment of ruptured abdominal aortic aneurysms. J Vasc Surg 2006; 43: 453-459.
Greco G, Egorova N, Gelijns A, Moskowitz A, Nowygrod R, Anderson P, Arons R, Parides M, McKinsey J, Kent K. Understanding the diffusion of vascular procedures: a quarter of a century experience. Trends in vascular surgery 2005;(Greenwood Academic): 443-454.
Ansari H, Greco G, Luban J. Cyclophilin A peptidyl–prolyl isomerase activity promotes ZPR1 nuclear export. Mol. Cell. Biol 2002; 22(PMC139809): 6993-7003.
Greco G, Pasqualini R, Schnapp LM. Matrix fibronectin increases HIV stability and infectivity. J. of Immunol 2002; 168: 5722-5729.
Tellier C, Greco G, Klotman M, Mosoian A, Cara A, Arap W, Ruoslahti E, Pasqualini R, Schnapp LM. Superfibronectin, a multimeric form of fibronectin increases HIV infection of primary CD4+ T lymphocytes. J. of Immunol 2000; 164: 3236-3245.
Greco G, Mackewicz C, Levy J. Sensitivity of HIV infection to various alpha, beta, and gamma chemokines. J. of General Virology 1999; 80: 2369-2373.
Greco G, Fujimura SH, Mourich D, Levy J. Differential effect of HIV isolates on beta-chemokine and Interferon gamma production and on cell proliferation. J. Virol 1999; 73(PMC103977): 1528-1534.
Greco G, Barker E, Levy J. Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production. AIDS Res. and Human Retroviruses 1998; 14: 1407-1411.
Gresser I, Greco G, Santini SM, Woodrow D, Mecchia M, Parlato S, Logozzi M, Venditti M, Maunoury MT, Belardelli F. Marked inhibition of Esb lymphoma metastases in mice using allogeneic immune and normal T lymphocytes and attempts to dissociate graft versus leukemia from graft-versus host disease. J. Interferon and Cytokine Research 1998; 18: 667-679.
Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Belardelli F. Cyclophosphamide -induced bystander effects on T cells and their importance for a successful tumor eradication in response to adoptive immunotherapy in mice. J. Clin. Invest 1998; 101: 429-441.